Viewing StudyNCT00338247



Ignite Creation Date: 2024-05-05 @ 4:52 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00338247
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2016-04-06
First Post: 2006-06-16

Brief Title: EAP Expanded Access Protocol Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Neoplasms Breast
Keywords:
Name View
Stage IIIc View
advanced View
TYKERB View
HER2 positive View
ErbB2 positive View
GW572016 View
metastatic View
Stage IIIb View
breast cancer View